{"nct_id":"NCT01561313","title":"Crossover Study of Safety and Tolerability of Two Formulations of Adalimumab.","status":"COMPLETED","status_verified_date":"2014-01","start_date":"2012-03","start_date_type":null,"primary_completion_date":"2012-11","primary_completion_date_type":"ACTUAL","completion_date":"2012-11","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["ABBV"]}